Phase 2 Dose Finding sPIF in Patients With High Panel Reactive Antibodies
Clinical trial NCT03593421 · WITHDRAWN
Trial details
- NCT number
- NCT03593421
- Sponsor
- Christopher O'Brien, MD
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-01
- Primary completion
- 2020-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.